Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
PHENYTEK®* Capsules (extended phenytoin sodium capsules, USP)
Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.
Flupirtine
Molecular characterization of a peripheral receptor for cannabinoids.
Biogen Idec reports death of patient on its MS pill
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Gordon Research Conference on Myelin Biology and Pathobiology of Myelinating Glia
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Masitinib is being investigated in the treatment of amyotrophic lateral sclerosis (ALS)
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS.
Gordon Research Conference on Ion Channels
Mitoxantrone-related acute leukemia in MS: An open or closed book?
Are changes in gait and balance across the Disease Step Rating Scale in Multiple Sclerosis statistically significant and clinically meaningful?
Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Teriflunomide for multiple sclerosis.
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Insight into the mechanism of laquinimod action.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.

Pages